Bile acid diarrhea-As bad as it gets?

Joelle Bousaba, Michael Camilleri

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of reviewBile acid diarrhea (BAD) is a common but under-recognized gastrointestinal condition that manifests with increased stool frequency and urgency, and a looser stool consistency. The aim of this review is to present recent advances in the pathophysiology, mechanisms, manifestations, diagnosis, and treatment of BAD.Recent findingsPatients with BAD have evidence of accelerated colonic transit, increased gut mucosal permeability, altered stool microbiome composition, and decreased quality of life. Single, random stool measurements of bile acids, alone or in combination with fasting serum 7-alpha-hydroxy-4-cholesten-3-one, have shown good sensitivity and specificity for the diagnosis of BAD. Novel therapeutic approaches include farnesoid X receptor agonists and glucagon-like peptide 1 agonists.SummaryRecent research has led to a better understanding of the pathophysiology and mechanisms of BAD, which might pave the way towards more targeted treatment strategies for BAD. Newer, more affordable, and easier diagnostic methods facilitate the diagnosis of BAD.

Original languageEnglish (US)
Pages (from-to)184-191
Number of pages8
JournalCurrent Opinion in Gastroenterology
Volume39
Issue number3
DOIs
StatePublished - May 1 2023

Keywords

  • 7-alpha-hydroxy-4-cholesten-3-one
  • fibroblast growth factor-19
  • mRNA
  • permeability
  • sequestrants

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Bile acid diarrhea-As bad as it gets?'. Together they form a unique fingerprint.

Cite this